{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:23:04Z","timestamp":1793157784122,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jpba.2021.113983","type":"journal-article","created":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T04:44:31Z","timestamp":1613882671000},"page":"113983","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Ruxolitinib photodegradation mechanisms by theoretical and experimental chemistry"],"prefix":"10.1016","volume":"197","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5838-3695","authenticated-orcid":false,"given":"Philippe-Henri","family":"Secretan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4443-8843","authenticated-orcid":false,"given":"Joel","family":"Schlatter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8500-3574","authenticated-orcid":false,"given":"Salvatore","family":"Cisternino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Antignac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9740-3380","authenticated-orcid":false,"given":"Olivier","family":"Thirion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7191-9423","authenticated-orcid":false,"given":"Hassane","family":"Sadou Yay\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Jouven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najet","family":"Yagoubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2021.113983_bib0005","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.1038\/sj.onc.1203925","article-title":"Janus kinases: components of multiple signaling pathways","volume":"19","author":"Rane","year":"2000","journal-title":"Oncogene."},{"key":"10.1016\/j.jpba.2021.113983_bib0010","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/2040620712459746","article-title":"Ruxolitinib: a potent and selective Janus kinase 1 and 2 inhibitor in patients with myelofibrosis","volume":"3","author":"Harrison","year":"2012","journal-title":"An update for clinicians, Ther. Adv. Hematol."},{"key":"10.1016\/j.jpba.2021.113983_bib0015","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s13555-019-00329-y","article-title":"Scoping review on the use of drugs targeting JAK\/STAT pathway in atopic dermatitis, vitiligo, and alopecia areata","volume":"9","author":"Montilla","year":"2019","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.jpba.2021.113983_bib0020","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/pharmaceutics12010010","article-title":"Photostability of topical agents applied to the skin: a review","volume":"12","author":"Kryczyk-Poprawa","year":"2019","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.jpba.2021.113983_bib0025","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.jaad.2017.02.049","article-title":"Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib","volume":"76","author":"Rothstein","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jpba.2021.113983_bib0030","doi-asserted-by":"crossref","first-page":"221","DOI":"10.5731\/pdajpst.2014.00974","article-title":"Advice on degradation products in pharmaceuticals: a toxicological evaluation","volume":"68","author":"Melo","year":"2014","journal-title":"PDA J. Pharm. Sci. Technol."},{"key":"10.1016\/j.jpba.2021.113983_bib0035","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/01480545.2011.588441","article-title":"In vitro evaluation of betamethasone esters for phototoxic potential","volume":"35","author":"Khattak","year":"2012","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.jpba.2021.113983_bib0040","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5530\/phm.2019.2.10","article-title":"A new stability indicating high performance liquid chromatography method for the estimation of ruxolitinib in bulk and tablet dosage form","volume":"10","author":"Biswal","year":"2019","journal-title":"Pharm. Methods"},{"key":"10.1016\/j.jpba.2021.113983_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113266","article-title":"Detection and structure elucidation of the new degradation impurities in the pharmaceutical formulations of ruxolitinib hydrobromide","volume":"186","author":"Dou\u0161a","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2021.113983_bib0050","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/1062936X.2012.657236","article-title":"Role of in silico genotoxicity tools in the regulatory assessment of pharmaceutical impurities","volume":"23","author":"Fioravanzo","year":"2012","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.jpba.2021.113983_bib0055","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1002\/qua.24481","article-title":"Jaguar: A high\u2010performance quantum chemistry software program with strengths in life and materials sciences","volume":"113","author":"Bochevarov","year":"2013","journal-title":"Int. J. Quantum Chem."},{"key":"10.1016\/j.jpba.2021.113983_bib0060","doi-asserted-by":"crossref","first-page":"8990","DOI":"10.1021\/jp202770c","article-title":"Evaluation of a combination of local hybrid functionals with DFT-D3 corrections for the calculation of thermochemical and kinetic data","volume":"115","author":"Theilacker","year":"2011","journal-title":"J. Phys. Chem. A"},{"key":"10.1016\/j.jpba.2021.113983_bib0065","doi-asserted-by":"crossref","first-page":"7484","DOI":"10.1021\/es101131h","article-title":"Quantum chemical investigation and experimental verification on the aquatic photochemistry of the sunscreen 2-Phenylbenzimidazole-5-Sulfonic acid","volume":"44","author":"Zhang","year":"2010","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.jpba.2021.113983_bib0070","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.compbiomed.2013.11.013","article-title":"Comprehension of drug toxicity: software and databases","volume":"45","author":"Toropov","year":"2014","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.jpba.2021.113983_bib0075","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/10629360802083871","article-title":"An evaluation of the implementation of the Cramer classification scheme in the Toxtree software","volume":"19","author":"Patlewicz","year":"2008","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.jpba.2021.113983_bib0080","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.1021\/jo4001417","article-title":"Application of Radical Cation Spin Density Maps toward the Prediction of Photochemical Reactivity betweenN -Methyl-1,2,4-triazoline-3,5-dione and Substituted Benzenes","volume":"78","author":"Breton","year":"2013","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.jpba.2021.113983_bib0085","doi-asserted-by":"crossref","first-page":"11306","DOI":"10.1021\/jp904171p","article-title":"Photodegradation mechanism of nonsteroidal anti-inflammatory drugs containing thiophene moieties: suprofen and tiaprofenic acid","volume":"113","author":"Musa","year":"2009","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.jpba.2021.113983_bib0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2019.115686","article-title":"Mass spectrometry-based structure elucidation of small molecule impurities and degradation products in pharmaceutical development","volume":"121","author":"Liu","year":"2019","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.jpba.2021.113983_bib0095","doi-asserted-by":"crossref","first-page":"35586","DOI":"10.1039\/C5RA00171D","article-title":"A comprehensive study of apixaban\u2019s degradation pathways under stress conditions using liquid chromatography coupled to multistage mass spectrometry","volume":"5","author":"Secr\u00e9tan","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.jpba.2021.113983_bib0100","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.scitotenv.2018.11.270","article-title":"Imatinib: Major photocatalytic degradation pathways in aqueous media and the relative toxicity of its transformation products","volume":"655","author":"Secr\u00e9tan","year":"2019","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.jpba.2021.113983_bib0105","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1021\/jo01062a004","article-title":"Reactions of hydrogen peroxide. VII. Alkali-catalyzed epoxidation and oxidation using a nitrile as Co-reactant","volume":"26","author":"Payne","year":"1961","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.jpba.2021.113983_bib0110","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1039\/b102066h","article-title":"Kinetics of acetonitrile-assisted oxidation of tertiary amines by hydrogen peroxide","volume":"2","author":"Laus","year":"2001","journal-title":"J. Chem. Soc. Perkin Trans. I"},{"key":"10.1016\/j.jpba.2021.113983_bib0115","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.yrtph.2016.09.016","article-title":"Results from oral gavage carcinogenicity studies of ruxolitinib in Tg.rasH2 mice and Sprague-Dawley (Crl:CD) rats","volume":"81","author":"Shuey","year":"2016","journal-title":"Regul. Toxicol. Pharmacol."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708521000959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708521000959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:13:01Z","timestamp":1760001181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708521000959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":23,"alternative-id":["S0731708521000959"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2021.113983","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ruxolitinib photodegradation mechanisms by theoretical and experimental chemistry","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2021.113983","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113983"}}